933 filings
Page 9 of 47
8-K
5vi r4aqv1c15
10 May 21
Avadel Pharmaceuticals Provides Corporate Update
8:07am
DEFA14A
mam6bdr49hzr8c0o4wwn
30 Apr 21
Additional proxy soliciting materials
4:14pm
8-K
w4hi gvpt1
19 Apr 21
Regulation FD Disclosure
7:29am
8-K
aoe5mv 3v
9 Mar 21
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
7:08am
8-K
q7dvuf5oqtr1s1g0pu
1 Mar 21
Other Events
8:06am
4
xgw682m96
17 Feb 21
AVADEL PHARMACEUTICALS / Richard J Kim ownership change
8:26am
3
2epypb98wvu4tanzo
17 Feb 21
AVADEL PHARMACEUTICALS / Richard J Kim ownership change
8:20am
8-K
56r2ju55fpjt2yi
17 Feb 21
Avadel Pharmaceuticals Appoints Richard Kim as Chief Commercial Officer to Lead the Commercial Launch of Once-Nightly FT218
8:07am
SC 13G
0nkw7xcfq6i9d7
16 Feb 21
AVADEL PHARMACEUTICALS / Polar Capital ownership change
7:32am
SC 13G/A
o0cli8atb5t80
12 Feb 21
AVADEL PHARMACEUTICALS / RTW INVESTMENTS ownership change
9:34am
SC 13G
v22dgaq4
12 Feb 21
AVADEL PHARMACEUTICALS / Avoro Capital Advisors ownership change
8:07am
SC 13G/A
dyokurbrbe5vlqta
11 Feb 21
AVADEL PHARMACEUTICALS / BRANDES INVESTMENT PARTNERS ownership change
4:21pm
S-8
q2cjr30lm clsyzc
10 Feb 21
Registration of securities for employees
4:47pm
UPLOAD
oqw9pba8
25 Jan 21
Letter from SEC
12:00am
4
p2pr 5sw6se
23 Dec 20
AVADEL PHARMACEUTICALS / Geoffrey Michael Glass ownership change
4:05pm
8-K
p0ai4hbjia mp9ewmpwr
16 Dec 20
Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA
8:05am
8-K
vo066kms
14 Dec 20
Regulation FD Disclosure
5:13pm